Director/PDRM shareholding

November 23, 2010 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), Europe’s leading adult stem cell storage bank, has been informed that Mr Marc Waeterschoot, Executive Director, purchased 20,000 ordinary shares of Euro 0.10 (‘Ordinary Shares’) at a price of €5.10 on 18 November 2010. Following this purchase, Marc Waeterschoot is beneficially interested in 1,853,850 ordinary shares, representing approximately 19.84% of the Group’s issued share capital.

read more

EN – Director/PDMR shareholding

August 2, 2010 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), Europe’s leading stem cell bank, has been informed today that Mr Marc Waeterschoot, Executive Director, purchased 23,850 ordinary shares of Euro 0.10 (‘Ordinary Shares’) at a price range between €5.64 and €5.80 between 26 July and 30 July 2010.

Following this purchase, Marc Waeterschoot is beneficially interested in 1,833,850 ordinary shares, representing approximately 19.84% of the Group’s issued share capital.

read more

NL – Director/PDMR shareholding

August 2, 2010 Group News

Aankoop aandelen Executive Director

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, of ‘de Groep’), de grootste stamcelbank van Europa, is vandaag geïnformeerd dat de heer Marc Waeterschoot, Executive Director, 23.850 aandelen Cryo-Save heeft gekocht in de periode van 26 juli tot en met 30 juli. De aankoopprijs lag tussen €5,64 en €5,80.

Het aandelenbelang in de Groep van de heer Waeterschoot na deze transacties bedraagt 1.833.850 aandelen, ofwel 19.84% van het geplaatst aandelenkapitaal van de Groep.

read more

EN – Director/PDMR Shareholding

July 27, 2010 Group News

Cryo-Save Group N.V.(Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), Europe’s leading stem cell bank, has been informed today that Mr Johan Goossens, Chairman, purchased 16,000 ordinary shares of Euro 0.10 (‘Ordinary Shares’) at €5.78 on 26 July 2010.

Following this purchase, Johan Goossens is beneficially interested in 1,671,000 ordinary shares, representing approximately 18.08% of the Company’s issued share capital.

read more

NL – Director/PDMR Shareholding

July 27, 2010 Group News

Aankoop aandelen Chairman

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, of ‘de Groep’), de grootste stamcelbank van Europa, is vandaag geïnformeerd dat de heer Johan Goossens, Chairman, 16.000 aandelen Cryo-Save heeft gekocht tegen €5,78 op 26 juli 2010.

Het aandelenbelang in de Groep van de heer Goossens na deze transactie bedraagt 1.671.000 aandelen, ofwel 18,08% van het geplaatst aandelenkapitaal van de Groep.

read more

EN – Director/PDMR Shareholding

July 27, 2010 Group News

Purchase shares Non-Executive Director

Cryo-Save Group N.V.(Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), Europe’s leading stem cell bank, has been informed today that Mr Walter van Pottelberge, Non-Executive Director, purchased 10,000 ordinary shares of Euro 0.10 (‘Ordinary Shares’) at €5.70 on 26 July 2010.

Following this purchase, Walter van Pottelberge is beneficially interested in 26,210 ordinary shares, representing approximately 0.28% of the Company’s issued share capital.

read more

EN – Director/PDMR Shareholding

May 17, 2010 Group News

Cryo-Save Group N.V.(AIM/Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), Europe’s leading stem cell bank, has been informed today that Mr Johan Goossens, Chairman, purchased 25,000 ordinary shares of Euro 0.10 (‘Ordinary Shares’) at €5.78 on 14 May 2010.

Following this purchase, Johan Goossens is beneficially interested in 1,655,000 ordinary shares, representing approximately 17.92% of the Company’s issued share capital.

read more

NL – Director/PDMR Shareholding

May 17, 2010 Group News

Aankoop aandelen Chairman

Cryo-Save Group N.V. (AIM/Euronext: CRYO, ‘Cryo-Save’, of ‘de Groep’), de grootste stamcelbank van Europa is vandaag geïnformeerd dat de heer Johan Goossens, Chairman, 25.000 aandelen Cryo-Save heeft gekocht tegen €5,78 op 14 mei 2010.

Het aandelenbelang in de Groep van de heer Goossens na deze transactie bedraagt 1.655.000 aandelen, ofwel ongeveer 17,92% van het geplaatst aandelenkapitaal van de Groep.

read more

EN – Director/PDMR Shareholding

April 12, 2010 Group News

Cryo-Save Group N.V.(AIM/Euronext: CRYO, or ‘the Group’), Europe’s leading stem cell bank, has been informed that Mr Marc Waeterschoot, Chief Executive Officer, purchased 17,296 ordinary shares of Euro 0.10 (‘Ordinary Shares’) at a price range between €5.66 and €5.70 between 7 April and 9 April 2010.

Following these purchases, Marc Waeterschoot is beneficially interested in 1,810,000 ordinary shares, representing approximately 19.60% of the Group’s issued share capital.

read more

NL – Director/PDMR Shareholding

April 12, 2010 Group News

Cryo-Save Group N.V. (AIM/Euronext: CRYO, of “de Groep”), de grootste stamcelbank van Europa is geïnformeerd dat de heer Marc Waeterschoot, Chief Executive Officer, 17.296 aandelen Cryo-Save heeft gekocht in de periode van 7 april tot en met 9 april 2010. De aankoopprijs lag tussen €5,66 en €5,70.

Het aandelenbelang in de Groep van de heer Waeterschoot na deze transacties bedraagt 1.810.000 aandelen, ofwel 19,60% van het geplaatst aandelenkapitaal van de Groep.

read more

Page 1 of 212